Global Drugs for Osteoarthritis Pain Market Insights, Forecast to 2029

Global Drugs for Osteoarthritis Pain Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Osteoarthritis Pain Market Perspective (2018-2029)
2.2 Global Drugs for Osteoarthritis Pain Growth Trends by Region
2.2.1 Drugs for Osteoarthritis Pain Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drugs for Osteoarthritis Pain Historic Market Size by Region (2018-2023)
2.2.3 Drugs for Osteoarthritis Pain Forecasted Market Size by Region (2024-2029)
2.3 Drugs for Osteoarthritis Pain Market Dynamics
2.3.1 Drugs for Osteoarthritis Pain Industry Trends
2.3.2 Drugs for Osteoarthritis Pain Market Drivers
2.3.3 Drugs for Osteoarthritis Pain Market Challenges
2.3.4 Drugs for Osteoarthritis Pain Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drugs for Osteoarthritis Pain by Players
3.1.1 Global Drugs for Osteoarthritis Pain Revenue by Players (2018-2023)
3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2018-2023)
3.2 Global Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drugs for Osteoarthritis Pain, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Drugs for Osteoarthritis Pain Market Concentration Ratio
3.4.1 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Osteoarthritis Pain Revenue in 2022
3.5 Global Key Players of Drugs for Osteoarthritis Pain Head office and Area Served
3.6 Global Key Players of Drugs for Osteoarthritis Pain, Product and Application
3.7 Global Key Players of Drugs for Osteoarthritis Pain, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Osteoarthritis Pain Breakdown Data by Type
4.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Type (2018-2023)
4.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2024-2029)
5 Drugs for Osteoarthritis Pain Breakdown Data by Application
5.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Application (2018-2023)
5.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drugs for Osteoarthritis Pain Market Size (2018-2029)
6.2 North America Drugs for Osteoarthritis Pain Market Size by Type
6.2.1 North America Drugs for Osteoarthritis Pain Market Size by Type (2018-2023)
6.2.2 North America Drugs for Osteoarthritis Pain Market Size by Type (2024-2029)
6.2.3 North America Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
6.3 North America Drugs for Osteoarthritis Pain Market Size by Application
6.3.1 North America Drugs for Osteoarthritis Pain Market Size by Application (2018-2023)
6.3.2 North America Drugs for Osteoarthritis Pain Market Size by Application (2024-2029)
6.3.3 North America Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
6.4 North America Drugs for Osteoarthritis Pain Market Size by Country
6.4.1 North America Drugs for Osteoarthritis Pain Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Drugs for Osteoarthritis Pain Market Size by Country (2018-2023)
6.4.3 North America Drugs for Osteoarthritis Pain Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Drugs for Osteoarthritis Pain Market Size (2018-2029)
7.2 Europe Drugs for Osteoarthritis Pain Market Size by Type
7.2.1 Europe Drugs for Osteoarthritis Pain Market Size by Type (2018-2023)
7.2.2 Europe Drugs for Osteoarthritis Pain Market Size by Type (2024-2029)
7.2.3 Europe Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
7.3 Europe Drugs for Osteoarthritis Pain Market Size by Application
7.3.1 Europe Drugs for Osteoarthritis Pain Market Size by Application (2018-2023)
7.3.2 Europe Drugs for Osteoarthritis Pain Market Size by Application (2024-2029)
7.3.3 Europe Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
7.4 Europe Drugs for Osteoarthritis Pain Market Size by Country
7.4.1 Europe Drugs for Osteoarthritis Pain Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Drugs for Osteoarthritis Pain Market Size by Country (2018-2023)
7.4.3 Europe Drugs for Osteoarthritis Pain Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drugs for Osteoarthritis Pain Market Size (2018-2029)
8.2 China Drugs for Osteoarthritis Pain Market Size by Type
8.2.1 China Drugs for Osteoarthritis Pain Market Size by Type (2018-2023)
8.2.2 China Drugs for Osteoarthritis Pain Market Size by Type (2024-2029)
8.2.3 China Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
8.3 China Drugs for Osteoarthritis Pain Market Size by Application
8.3.1 China Drugs for Osteoarthritis Pain Market Size by Application (2018-2023)
8.3.2 China Drugs for Osteoarthritis Pain Market Size by Application (2024-2029)
8.3.3 China Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Drugs for Osteoarthritis Pain Market Size (2018-2029)
9.2 Asia Drugs for Osteoarthritis Pain Market Size by Type
9.2.1 Asia Drugs for Osteoarthritis Pain Market Size by Type (2018-2023)
9.2.2 Asia Drugs for Osteoarthritis Pain Market Size by Type (2024-2029)
9.2.3 Asia Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
9.3 Asia Drugs for Osteoarthritis Pain Market Size by Application
9.3.1 Asia Drugs for Osteoarthritis Pain Market Size by Application (2018-2023)
9.3.2 Asia Drugs for Osteoarthritis Pain Market Size by Application (2024-2029)
9.3.3 Asia Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
9.4 Asia Drugs for Osteoarthritis Pain Market Size by Region
9.4.1 Asia Drugs for Osteoarthritis Pain Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Drugs for Osteoarthritis Pain Market Size by Region (2018-2023)
9.4.3 Asia Drugs for Osteoarthritis Pain Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Drugs for Osteoarthritis Pain Introduction
11.1.4 Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.1.5 Pfizer Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Introduction
11.2.4 Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.2.5 Johnson & Johnson Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Introduction
11.3.4 GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.3.5 GlaxoSmithKline Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Drugs for Osteoarthritis Pain Introduction
11.4.4 Bayer Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.4.5 Bayer Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Introduction
11.5.4 Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.5.5 Eli Lilly Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Drugs for Osteoarthritis Pain Introduction
11.6.4 Novartis Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.6.5 Novartis Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Drugs for Osteoarthritis Pain Introduction
11.7.4 Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.7.5 Sanofi Recent Developments
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Details
11.8.2 Horizon Pharma Business Overview
11.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Introduction
11.8.4 Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.8.5 Horizon Pharma Recent Developments
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Drugs for Osteoarthritis Pain Introduction
11.9.4 Abbott Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.9.5 Abbott Recent Developments
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Drugs for Osteoarthritis Pain Introduction
11.10.4 Mylan Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.10.5 Mylan Recent Developments
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Details
11.11.2 Daiichi Sankyo Business Overview
11.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Introduction
11.11.4 Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.11.5 Daiichi Sankyo Recent Developments
11.12 TEVA
11.12.1 TEVA Company Details
11.12.2 TEVA Business Overview
11.12.3 TEVA Drugs for Osteoarthritis Pain Introduction
11.12.4 TEVA Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.12.5 TEVA Recent Developments
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Details
11.13.2 Almatica Pharma Business Overview
11.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Introduction
11.13.4 Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.13.5 Almatica Pharma Recent Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Details
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Introduction
11.14.4 Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.14.5 Astellas Pharma Recent Developments
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Details
11.15.2 Tide Pharmaceutical Business Overview
11.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Introduction
11.15.4 Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.15.5 Tide Pharmaceutical Recent Developments
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Details
11.16.2 Iroko Pharmaceuticals Business Overview
11.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Introduction
11.16.4 Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.16.5 Iroko Pharmaceuticals Recent Developments
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Details
11.17.2 Hengrui Pharmaceutical Business Overview
11.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Introduction
11.17.4 Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.17.5 Hengrui Pharmaceutical Recent Developments
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Details
11.18.2 Abiogen Pharma Business Overview
11.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Introduction
11.18.4 Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023)
11.18.5 Abiogen Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of External
Table 5. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Drugs for Osteoarthritis Pain Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Drugs for Osteoarthritis Pain Market Share by Region (2018-2023)
Table 9. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Drugs for Osteoarthritis Pain Market Share by Region (2024-2029)
Table 11. Drugs for Osteoarthritis Pain Market Trends
Table 12. Drugs for Osteoarthritis Pain Market Drivers
Table 13. Drugs for Osteoarthritis Pain Market Challenges
Table 14. Drugs for Osteoarthritis Pain Market Restraints
Table 15. Global Drugs for Osteoarthritis Pain Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Drugs for Osteoarthritis Pain Revenue Share by Players (2018-2023)
Table 17. Global Top Drugs for Osteoarthritis Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2022)
Table 18. Global Drugs for Osteoarthritis Pain Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Drugs for Osteoarthritis Pain Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Drugs for Osteoarthritis Pain, Headquarters and Area Served
Table 21. Global Key Players of Drugs for Osteoarthritis Pain, Product and Application
Table 22. Global Key Players of Drugs for Osteoarthritis Pain, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drugs for Osteoarthritis Pain Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2018-2023)
Table 26. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2024-2029)
Table 28. Global Drugs for Osteoarthritis Pain Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Drugs for Osteoarthritis Pain Revenue Share by Application (2018-2023)
Table 30. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Drugs for Osteoarthritis Pain Revenue Share by Application (2024-2029)
Table 32. North America Drugs for Osteoarthritis Pain Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Drugs for Osteoarthritis Pain Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Drugs for Osteoarthritis Pain Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Drugs for Osteoarthritis Pain Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Drugs for Osteoarthritis Pain Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Drugs for Osteoarthritis Pain Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Drugs for Osteoarthritis Pain Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Drugs for Osteoarthritis Pain Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Drugs for Osteoarthritis Pain Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Drugs for Osteoarthritis Pain Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Drugs for Osteoarthritis Pain Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Drugs for Osteoarthritis Pain Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Drugs for Osteoarthritis Pain Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Drugs for Osteoarthritis Pain Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Drugs for Osteoarthritis Pain Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Drugs for Osteoarthritis Pain Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Drugs for Osteoarthritis Pain Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Drugs for Osteoarthritis Pain Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Drugs for Osteoarthritis Pain Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Drugs for Osteoarthritis Pain Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Drugs for Osteoarthritis Pain Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Drugs for Osteoarthritis Pain Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Drugs for Osteoarthritis Pain Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Drugs for Osteoarthritis Pain Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Drugs for Osteoarthritis Pain Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Country (2024-2029) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Drugs for Osteoarthritis Pain Product
Table 67. Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 68. Pfizer Recent Developments
Table 69. Johnson & Johnson Company Details
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Drugs for Osteoarthritis Pain Product
Table 72. Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 73. Johnson & Johnson Recent Developments
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Drugs for Osteoarthritis Pain Product
Table 77. GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 78. GlaxoSmithKline Recent Developments
Table 79. Bayer Company Details
Table 80. Bayer Business Overview
Table 81. Bayer Drugs for Osteoarthritis Pain Product
Table 82. Bayer Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 83. Bayer Recent Developments
Table 84. Eli Lilly Company Details
Table 85. Eli Lilly Business Overview
Table 86. Eli Lilly Drugs for Osteoarthritis Pain Product
Table 87. Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 88. Eli Lilly Recent Developments
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Drugs for Osteoarthritis Pain Product
Table 92. Novartis Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 93. Novartis Recent Developments
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Drugs for Osteoarthritis Pain Product
Table 97. Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 98. Sanofi Recent Developments
Table 99. Horizon Pharma Company Details
Table 100. Horizon Pharma Business Overview
Table 101. Horizon Pharma Drugs for Osteoarthritis Pain Product
Table 102. Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 103. Horizon Pharma Recent Developments
Table 104. Abbott Company Details
Table 105. Abbott Business Overview
Table 106. Abbott Drugs for Osteoarthritis Pain Product
Table 107. Abbott Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 108. Abbott Recent Developments
Table 109. Mylan Company Details
Table 110. Mylan Business Overview
Table 111. Mylan Drugs for Osteoarthritis Pain Product
Table 112. Mylan Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 113. Mylan Recent Developments
Table 114. Daiichi Sankyo Company Details
Table 115. Daiichi Sankyo Business Overview
Table 116. Daiichi Sankyo Drugs for Osteoarthritis Pain Product
Table 117. Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 118. Daiichi Sankyo Recent Developments
Table 119. TEVA Company Details
Table 120. TEVA Business Overview
Table 121. TEVA Drugs for Osteoarthritis Pain Product
Table 122. TEVA Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 123. TEVA Recent Developments
Table 124. Almatica Pharma Company Details
Table 125. Almatica Pharma Business Overview
Table 126. Almatica Pharma Drugs for Osteoarthritis Pain Product
Table 127. Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 128. Almatica Pharma Recent Developments
Table 129. Astellas Pharma Company Details
Table 130. Astellas Pharma Business Overview
Table 131. Astellas Pharma Drugs for Osteoarthritis Pain Product
Table 132. Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 133. Astellas Pharma Recent Developments
Table 134. Tide Pharmaceutical Company Details
Table 135. Tide Pharmaceutical Business Overview
Table 136. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 137. Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 138. Tide Pharmaceutical Recent Developments
Table 139. Iroko Pharmaceuticals Company Details
Table 140. Iroko Pharmaceuticals Business Overview
Table 141. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product
Table 142. Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 143. Iroko Pharmaceuticals Recent Developments
Table 144. Hengrui Pharmaceutical Company Details
Table 145. Hengrui Pharmaceutical Business Overview
Table 146. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 147. Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 148. Hengrui Pharmaceutical Recent Developments
Table 149. Abiogen Pharma Company Details
Table 150. Abiogen Pharma Business Overview
Table 151. Abiogen Pharma Drugs for Osteoarthritis Pain Product
Table 152. Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2018-2023) & (US$ Million)
Table 153. Abiogen Pharma Recent Developments
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Drugs for Osteoarthritis Pain Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. External Features
Figure 6. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Drugs for Osteoarthritis Pain Market Share by Application: 2022 VS 2029
Figure 8. Medical Care Case Studies
Figure 9. Personal Care Case Studies
Figure 10. Drugs for Osteoarthritis Pain Report Years Considered
Figure 11. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Drugs for Osteoarthritis Pain Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Drugs for Osteoarthritis Pain Market Share by Region: 2022 VS 2029
Figure 14. Global Drugs for Osteoarthritis Pain Market Share by Players in 2022
Figure 15. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2022
Figure 17. North America Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
Figure 19. North America Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
Figure 20. North America Drugs for Osteoarthritis Pain Market Share by Country (2018-2029)
Figure 21. United States Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Drugs for Osteoarthritis Pain Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
Figure 25. Europe Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
Figure 26. Europe Drugs for Osteoarthritis Pain Market Share by Country (2018-2029)
Figure 27. Germany Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Drugs for Osteoarthritis Pain Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
Figure 35. China Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
Figure 36. Asia Drugs for Osteoarthritis Pain Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
Figure 38. Asia Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
Figure 39. Asia Drugs for Osteoarthritis Pain Market Share by Region (2018-2029)
Figure 40. Japan Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Share by Country (2018-2029)
Figure 50. Brazil Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Drugs for Osteoarthritis Pain Market Size YoY Growth (2018-2029) & (US$ Million)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs